MiYé, the French brand of skincare products and dietary supplements dedicated to women's hormonal balance and well-being, announces that Laboratoires Pierre Fabre has taken a stake in the company, which was founded in 2020. This first capital increase will enable MiYé to accelerate its development by benefiting from the medical expertise of Pierre Fabre Laboratories and their knowledge of the pharmacy channel.
MiYé, "the good friend" in Provençal, is a brand created by women for women, to help them live better with their hormonal variations and improve their quality of life from puberty to menopause. Co-founded by Caroline de Blignières and Anna Oualid, with the support of a scientific committee specialized in the hormonal system, MiYé has chosen to tackle the hormonal well-being market. In an innovative and disruptive way, the brand targets the root causes of often taboo and misidentified symptoms due to hormonal imbalances. Today, it offers a complete range of 13 products (5 dietary supplements and 8 dermo-cosmetics) focused on performance, naturalness, safety and ease of use.
Since their origins in 1962, Pierre Fabre Laboratories have been active in women's health through a broad portfolio of drugs and dermo-cosmetics. Through their investment subsidiary Pierre Fabre Invest, they pursue a strategy of acquiring stakes in fast-growing start-ups whose positioning complements their established dermo-cosmetics brands. Pierre Fabre Invest has thus become the majority shareholder in Ladrôme Laboratoire (specializing in organic skincare and cosmetics) in 2021, and the sole shareholder in Même Cosmetics (specializing in wellness treatments for cancer patients) in 2022. Today, she becomes MiYé's sole minority shareholder alongside the two co-founders.
Caroline de Blignières, co-founder of MiYé, comments: ". Pierre Fabre Laboratories' acquisition of a stake in the company two years after our launch is a tremendous recognition. It's an invaluable opportunity to strengthen our R&D resources to promote the democratization of women's hormonal health and, together, redefine the rules of a new ecology for the female body that is holistic, transgenerational and, above all, safer.
Anna Oualid, co-founder of MiYé, adds: "When we launched MiYé, we set ourselves an ambitious goal: to democratize a medical subject using cosmetics codes that are as close as possible to women's routines, via premium, multi-channel distribution. Who could be more legitimate than Pierre Fabre, historically committed to women's health, to support us today?"
This strategic alliance with Laboratoires Pierre Fabre will enable MiYé to accelerate its R&D investments, carry out clinical studies, reinforce the scientific and medical backing of its flagship products, and continue its development in the pharmacy and parapharmacies channel. In the short term, MiYé is preparing to develop an awareness-raising and personalized support program via online consultations with naturopaths and micro-nutritionists.
Frédéric Ennabli, CEO Pierre Fabre Dermo-Cosmétique, explains: "Hormonal balance is a major challenge to which dermo-cosmetics must be able to respond. With MiYé, Caroline de Blignières and Anna Oualid have succeeded in supporting women from puberty to menopause. They have created a brand with a strong territory, with specialized, cutting-edge products that are now recognized by consumers, such as the Cycles Heureux Serum.
In joining forces with MiYé, we are committed to contributing our medical and dermatological expertise to developing the best possible solutions for all skin types affected by hormonal variations.
In this way, we are continuing Pierre Fabre's long-standing commitment to women's health issues and enabling pharmacists to respond to them in the best possible way, whether through our care products, our medicines, notably by pioneering the treatment of iron deficiency anaemia, a very common condition during pregnancy, and now through this strategic partnership."
Photo: ©DR (photo of the www.miye.care )
